healthconservative
Pharma Trade Pact: What's In It For The U. S. ?
United States, USATuesday, December 2, 2025
Advertisement
Advertisement
Key Points
- Trade Agreement Details:
- Eliminates tariffs on U.K. medicines exported to the U.S. for three years.
Catch: U.K. drug companies must invest more in the U.S. and create jobs.
- Balancing Trade:
- Praised for balancing trade between the two countries.
- Criticism: The American Hospital Association has filed a lawsuit to block a pilot program that changes payments for medicines bought through a federal drug discount program.
Pharmaceutical Industry Updates
Eli Lilly Cuts Price of Weight-Loss Drug
- Zepbound price cut by up to 20% for cash-paying customers.
- Reason: Competition with Novo Nordisk heats up.
World Health Organization (WHO) Guidelines
- New guidelines recommend long-term use of GLP-1 medications for adults with obesity.
- Caution: These drugs alone won't solve the global obesity crisis.
State-Level Decisions
- Some states are choosing not to cover new weight-loss drugs under Medicaid.
- Implications: Could affect prevention of diseases like cancer, diabetes, and heart disease.
Actions
flag content